Biomarkers for postoperative renal failure after EVAR are extremely debated in the literature, with some having strong references (NGAL, cystatin C) and others having weaker data to support their use (retinol binding protein, IL-18, N-acetyle-b-D-glocosaminidase). The gene discussed is CST3; the disease is acute kidney injury.